1/37
Looks like no tags are added yet.
Pancytopenia
Refers to a CBC finding in which all peripheral blood cell lineage counts are below the reference ranges
Bicytopenia
Refers to decreases in only two cell lines
RBCs: Hemoglobin <12 g/dL (non-pregnant females) or <13 g/dL (males)
Absolute Reticulocyte Count <40 x 10^9 /L.
WBCs: Absolute Neutrophil Count (ANC) <1.8 x 10^9 /L (most leukopenias manifest as neutropenia).
Platelets: <150 x 10^9 /L.
Pancytopenia CBC findings
DIC, TTP, Hypersplenism
Peripheral destruction/sequestration
Infiltration/Replacement, Nutritional Deficiencies, Marrow Infections
Non-AA Bone Marrow failure
Vitamin B12, folate, zinc, copper
Nutritional deficiencies causing BM failure
Bone marrow failure
Refers to decreased production of ≥ 1 major hematopoietic lineage, leading to diminished/absent marrow precursors and peripheral cytopenias
Aplastic anemia
Defined as pancytopenia with a hypocellular bone marrow in the absence of an abnormmal infiltrate or marrow fibrosis
Loss of hematopoietic stem cells
Defining feature of aplastic anemia, which resemble lymphoid cells morphologically and are identified via immunophenotyping as CD34+/CD38-
Results in decrease of mature blood cells
Severe AA
Bone marrow cellularity < 25%
At least 2 of:
ANC <0.5 x 10^9 /L,
Platelets <20 x 10^9 /L
Reticulocytes <20 x 10^9/L
Very severe AA
Bone marrow cellularity < 25%
Meets SAA criteria AND ANC <0.2 x 10^9 /L
Non-severe AA
Hypocellular bone marrow
ANC <1.8 x 10^9 /L
Platelets <150 x 10^9 /L
Reticulocytes <40 x 10^9 /L
Immunosuppressive Therapy (IST)
Anti-thymocyte globulin (ATG) + Cyclosporine (CsA)
80% of AA patients will respond to this treatment
Not helpful for most inherited forms of BMF
Indirect injury through autoimmune mechanisms
Direct injury to HSCs by drugs, chemical, viral infection, irradiation
Mechanisms of HSC Loss
Direct hematopoietic injury
Cytotoxic chemotherapeutic drugs, irradiation, chemicals and viruses cause damage to hematopoietic stem cells
CD4+ T cells release IFN-γ and TNF
Immune-Mediated Mechanism
Induces Fas-mediated apoptosis and blocking growth factor signaling; cytotoxic lymphocytes also destroy HSCs
Drugs (Dose-dependent/Predictable)
Alkylating agents (busulfan, melphalan, cyclophosphamide)
Antimetabolites (antifolic compounds, nucleotide analogs)
Antimitotics (vincristine, vinblastine, colchicine)
Anthracyclines (daunorubicin, doxorubicin)
Azathioprine, phenylbutazone, gold, chloramphenicol
Doses higher than 1.5-2 Gy
This dose of ionizing radiation can cause BM hypoplasia to the whole body (Predictable, dose-dependent bone marrow suppressive effect, direct toxicity)
Lindane, pesticides, benzenes
Toxins that can cause acquired AA
Viral infection (Hepatitis viruses, EBV, HIV)
Alters antigen on HSCs and activate a cytotoxic T cell clone or initiate T cell release of cytokines
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Acquired mutations of the PIG-A gene → Loss of CD59 → complement-mediated lysis and immune HSC attack
Inherited Bone Marrow Failure Syndromes
Caused by germline mutations; usually present in the 1st decade of life (though can present in adults) with pancytopenia symptoms (fatigue/pallor, bleeding, recurrent bacterial infections) plus syndrome-specific physical anomalies
Do not respond to IST
Fanconi Anemia
AR (2% XLR), Most common IBMFS
Mutations in DNA damage repair (FANC complex—most common; BRCA2 subset → breast/ovarian cancer risk)
Short stature, microcephaly, absent radii/thumbs, café-au-lait spots, renal/cardiac defects, hypogonadism. High early risk (<40 yrs) of MDS, AML, and SCC.
Dyskeratosis Congenita (DC)
XLR, AD, AR
Defect in telomere maintenance (DKC1, TERC, TERT, etc.) → short telomeres & premature HSC exhaustion
Mucocutaneous triad: Lacy reticulated skin pigmentation, dystrophic nails, oral leukoplakia (plus maldentition, premature graying/alopecia, pulmonary fibrosis, MDS/AML/SCC risk)
Shwachman-Diamond Syndrome (SDS)
AR
Defect in Ribosome biogenesis & mitotic spindle (SBDS gene)
Marrow failure + exocrine pancreatic insufficiency / skeletal abnormalities
Congenital Amegakaryocytic Thrombocytopenia (CAMT)
AR
Mutation in Thrombopoietin receptor (c-MPL gene mutation)
Severe thrombocytopenia in infancy (absent/reduced marrow megakaryocytes) → progresses to aplastic anemia and MDS/AML in later childhood
Reticular Dysgenesis (RD)
AR / AD; Rarest and most severe form of SCID
Mutation in mitochondrial adenylate kinase 2 (AK2)
Profound neutropenia + decreased T and NK cells, low/absent B cells → early severe infections
Blackfan-Diamond Anemia (BDA)
AD; Inherited Pure Red Cell Aplasia (isolated erythroid failure early in life; acquired form is linked to thymoma
Mutation in Ribosomal proteins (RPL and RPS families
Low birth weight, short stature, triphalangeal thumbs
Dry tap
Bone Marrow Aspirate findings
DDX: myelofibrosis, metastatic carcinoma, multiple myeloma
Markedly hypocellular marrow replaced by fat (yellow marrow)
Bone Marrow Biopsy findings
Decreased erythropoiesis, myelopoiesis, and megakaryopoiesis
Lymphocytes
Predominant cells in residual hematopoietic cells seen in bone marrow aspirates/biopsies
Flow cytometry
Evaluates CD59 on RBCs to screen for PNH; rules out MDS and acute leukemia
PCR & Next Generation Sequencing
Screening germline DNA for genes responsible for FA, telemeropathy, and Schwachman-Bodian-Diamond syndrome, etc.
Diepoxybutane (DEB) / Mitomycin C (MMC) Test
Diagnostic gold standard for Fanconi Anemia; lymphocytes exposed to DNA cross-linking agents show markedly increased chromosomal breakage and radial formations (confirm with 22-gene NGS panel).
Leukoreduced RBC transfusions
Blood component transfusion for Hb <7 g/dL
Platelet transfusions
Blood component transfusion for platelets <10,000 /uL, or <50,000 /uL with active bleeding
Hematopoietic Stem Cell Transplant (HSCT)
Definitive treatment for inherited BMD syndromes
Androgen Therapy (Decanoate, oxymetholone, danazol)
Increase telomerase gene transcription and danazol has been effective in marrow failure due to telomeropathy